Does TOFACITINIB Cause Type 2 diabetes mellitus? 2,744 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,744 reports of Type 2 diabetes mellitus have been filed in association with TOFACITINIB (XELJANZ XR). This represents 1.8% of all adverse event reports for TOFACITINIB.
2,744
Reports of Type 2 diabetes mellitus with TOFACITINIB
1.8%
of all TOFACITINIB reports
1,651
Deaths
1,652
Hospitalizations
How Dangerous Is Type 2 diabetes mellitus From TOFACITINIB?
Of the 2,744 reports, 1,651 (60.2%) resulted in death, 1,652 (60.2%) required hospitalization, and 1,759 (64.1%) were considered life-threatening.
Is Type 2 diabetes mellitus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 2,744 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Type 2 diabetes mellitus?
ATORVASTATIN (7,556)
ADALIMUMAB (3,516)
PREDNISONE (3,484)
METHOTREXATE (3,465)
RITUXIMAB (3,318)
TOCILIZUMAB (3,145)
ABATACEPT (3,074)
LEFLUNOMIDE (3,033)
ALENDRONATE (3,002)
DICLOFENAC (2,974)
Which TOFACITINIB Alternatives Have Lower Type 2 diabetes mellitus Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN